MoonLake Immunotherapeutics

NasdaqCM MLTX

MoonLake Immunotherapeutics Share Price on January 14, 2025: USD 46.50

MoonLake Immunotherapeutics Share Price is USD 46.50 on January 14, 2025, a -19.35% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.

MoonLake Immunotherapeutics 52-week high Share Price is USD 63.86 on February 12, 2024, which is 37.33% above the current Share Price.
MoonLake Immunotherapeutics 52-week low Share Price is USD 38.43 on June 21, 2024, which is -17.35% below the current Share Price.
MoonLake Immunotherapeutics average Share Price for the last 52 weeks is USD 48.30.

Key data

Date	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)

NasdaqCM: MLTX

MoonLake Immunotherapeutics

CEO	Dr. Jorge Santos da Silva
IPO Date	Oct. 20, 2020
Location	Switzerland
Headquarters	Dorfstrasse 29
Employees	50
Sector	Health Care
Industries Pharmaceuticals Biotechnology Clinical Trials

Description

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.

Key trends

Past 5 years